Mirati Therapeutics, Inc. announced the appointment of Laurie Stelzer as the Company's Chief Financial Officer (CFO) effective May 16, 2022. Laurie will report to the Company's Chief Executive Officer, David Meek. Laurie joins the Company most recently from Arena Pharmaceuticals, Inc. (acquired by Pfizer) where she served as Executive Vice President and CFO since 2020.

She brings 25 years of biopharma industry experience to her role in leading the company's finance functions. Prior to joining Arena, Laurie was the CFO at Halozyme Therapeutics where she led the finance, information technology, business development, project management and site operations organizations. Vickie Reed, Mirati's Chief Accounting Officer, filled the role of Mirati's Principal Accounting Officer and on an interim basis, the Principal Financial Officer, and will be retiring from Mirati later this year.